
Evora Biosciences develops EVOGEX, a proprietary therapeutic discovery platform for exosome-based treatments.
Our off-the-shelf exosomes are engineered for improved efficacy, and we aim to disrupt the field of regenerative medicine and beyond.

Evora Bioscience heralded as one of France’s top 15 biotechs to invest in.
Challenges Magazine – March 2022